Rachele Fornari1, Chiara Marocco1, Davide Francomano1, Simona Fittipaldi2, Carla Lubrano1, Viviana M Bimonte3, Lorenzo M Donini1, Emanuele Nicolai2, Antonio Aversa4, Andrea Lenzi1, Emanuela A Greco1, Silvia Migliaccio5. 1. Department of Experimental Medicine, Section of Medical Pathophysiology, Endocrinology and Nutrition, University "Sapienza", Rome, Italy. 2. IRCCS SDN, Naples, Italy. 3. Department of Movement, Human and Health Sciences, Section of Health Sciences, University "Foro Italico", Largo Lauro De Bosis 6, 00135, Rome, Italy. 4. Department of Experimental and Clinical Medicine, University Magna Graecia, Catanzaro, Italy. 5. Department of Movement, Human and Health Sciences, Section of Health Sciences, University "Foro Italico", Largo Lauro De Bosis 6, 00135, Rome, Italy. silvia.migliaccio@uniroma4.it.
Abstract
PURPOSE: Obesity is a severe public health problem worldwide, leading to an insulin-resistant state in liver, adipose, and muscle tissue, representing a risk factor for type 2 diabetes mellitus, cardiovascular diseases, and cancer. We have shown that abdominal obesity is associated with homeostasis derangement, linked to several hormonal and paracrine factors. Data regarding potential link between GH/IGF1 axis, bone mineral density, and inflammation in obesity are lacking. Thus, aim of this study was to evaluate correlation among IGF-1, BMD, and inflammation in obese individuals. METHODS: The study included 426 obese subjects, mean age 44.8 ± 14 years; BMI 34.9 ± 6.1. Exclusion criteria were chronic medical conditions, use of medications affecting bone metabolism, hormonal and nutritional status, recent weight loss, and prior bariatric surgery. Patients underwent measurements of BMD and body composition by DEXA and were evaluated for hormonal, metabolic profile, and inflammatory markers. RESULTS: In this population, IGF-1 was inversely correlated with abdominal FM% (p < 0.001, r 2 = 0.12) and directly correlated with osteocalcin (OSCA) (p < 0.002, r 2 = 0.14). A negative correlation was demonstrated between IGF-1 levels and nonspecific inflammatory index, such as fibrinogen (p < 0.01, r 2 = 0.04) and erythrocyte sedimentation rate (p < 0.0001, r 2 = 0.03). IGF-1 was directly correlated with higher BMD, at both lumbar (p < 0.02, r 2 = 0.03) and femoral site (p < 0.04, r 2 = 0.03). CONCLUSIONS: In conclusion, our results show that higher levels of serum IGF-1 in obese patients correlate with lower inflammatory pattern and better skeletal health, as demonstrated by higher BMD and osteocalcin levels. These results lead to speculate the existence of a bone-adipose-muscle interplay modulating energy homeostasis, glucose, bone metabolism, and chronic inflammation in individuals affected by abdominal obesity.
PURPOSE:Obesity is a severe public health problem worldwide, leading to an insulin-resistant state in liver, adipose, and muscle tissue, representing a risk factor for type 2 diabetes mellitus, cardiovascular diseases, and cancer. We have shown that abdominal obesity is associated with homeostasis derangement, linked to several hormonal and paracrine factors. Data regarding potential link between GH/IGF1 axis, bone mineral density, and inflammation in obesity are lacking. Thus, aim of this study was to evaluate correlation among IGF-1, BMD, and inflammation in obese individuals. METHODS: The study included 426 obese subjects, mean age 44.8 ± 14 years; BMI 34.9 ± 6.1. Exclusion criteria were chronic medical conditions, use of medications affecting bone metabolism, hormonal and nutritional status, recent weight loss, and prior bariatric surgery. Patients underwent measurements of BMD and body composition by DEXA and were evaluated for hormonal, metabolic profile, and inflammatory markers. RESULTS: In this population, IGF-1 was inversely correlated with abdominal FM% (p < 0.001, r 2 = 0.12) and directly correlated with osteocalcin (OSCA) (p < 0.002, r 2 = 0.14). A negative correlation was demonstrated between IGF-1 levels and nonspecific inflammatory index, such as fibrinogen (p < 0.01, r 2 = 0.04) and erythrocyte sedimentation rate (p < 0.0001, r 2 = 0.03). IGF-1 was directly correlated with higher BMD, at both lumbar (p < 0.02, r 2 = 0.03) and femoral site (p < 0.04, r 2 = 0.03). CONCLUSIONS: In conclusion, our results show that higher levels of serum IGF-1 in obesepatients correlate with lower inflammatory pattern and better skeletal health, as demonstrated by higher BMD and osteocalcin levels. These results lead to speculate the existence of a bone-adipose-muscle interplay modulating energy homeostasis, glucose, bone metabolism, and chronic inflammation in individuals affected by abdominal obesity.
Entities:
Keywords:
Bone mineral density; IGF-1; Inflammation; Obesity
Authors: Nathan K Lebrasseur; Sara J Achenbach; L Joseph Melton; Shreyasee Amin; Sundeep Khosla Journal: J Bone Miner Res Date: 2012-10 Impact factor: 6.741
Authors: R Fornari; D Francomano; E A Greco; C Marocco; C Lubrano; F Wannenes; V Papa; V M Bimonte; L M Donini; A Lenzi; A Aversa; S Migliaccio Journal: J Endocrinol Invest Date: 2014-10-29 Impact factor: 4.256
Authors: Joselina L M Oliveira; Manuel H Aguiar-Oliveira; Argemiro D'Oliveira; Rossana M C Pereira; Carla R P Oliveira; Catarine T Farias; José A Barreto-Filho; Fernando D Anjos-Andrade; Celi Marques-Santos; Adão C Nascimento-Junior; Erica O Alves; Francielle T Oliveira; Viviane C Campos; Roberto Ximenes; Amanda Blackford; Giovanni Parmigiani; Roberto Salvatori Journal: J Clin Endocrinol Metab Date: 2007-10-02 Impact factor: 5.958
Authors: Umberto Tarantino; Chiara Greggi; Ida Cariati; Virginia Veronica Visconti; Monica Gasparini; Marco Cateni; Elena Gasbarra; Annalisa Botta; Antonietta Salustri; Manuel Scimeca Journal: Front Immunol Date: 2021-01-29 Impact factor: 7.561
Authors: Elena Gangitano; Giuseppe Barbaro; Martina Susi; Rebecca Rossetti; Maria Elena Spoltore; Davide Masi; Rossella Tozzi; Stefania Mariani; Lucio Gnessi; Carla Lubrano Journal: Cells Date: 2022-08-04 Impact factor: 7.666